Resources

Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C

Showing 1 to 10 of 240 resources

  • HCV Action ODN Stakeholder Event 2020: A national perspective on elimination
    These are the opening talks from this year's ODN Stakeholder Event from Mark Gillyon-Powell, Head of Programme for HCV Elimination, NHS England and Prof Graham Foster, National Clinical Lead for ODNs, NHS England. The talks gives a national overview on hepatitis C elimination efforts in England and how COVID-19 has impacted these. Professor Guruprasad Aithal, President of the British Association for the Study of the Liver (BASL) chaired the event. We will be publishing a written summary of the other presentations from this event soon.
    England 07 Oct 2020 Other, Strategy & Planning Video
  • A glossary of contested terms in substance use
    This is a glossary of terms used by people working in the drugs field, drawn up by the Scottish Drugs Forum. It covers some of the specialised and contentious language used in the field. We have included it in the resource library as it may be helpful to those who work in health services who are less familiar with some of the language and terms used by colleagues and partners in drug services.
    UK 07 Oct 2020 Training, Reports & Research PDF
  • Unlinked Anonymous Monitoring (UAM) Survey of HIV and viral hepatitis among PWID: 2020 report
    The 2020 edition of the Unlinked Anonymous Monitoring (UAM) Survey of HIV and viral hepatitis among PWID contains a number of relevant updates on hepatitis C among injecting drug users, including: • The proportion of UAM participants with antibodies to hepatitis C (HCV) (i.e. ever infected) who have markers of chronic infection (RNA) has decreased from 58% in 2011 when it was first measured to 42% in 2019; this corresponds with the timing of the scale-up of direct acting antiviral treatment against HCV among PWID
    UK 06 Oct 2020 Reports & Research PDF
  • Understanding the Sexual Health and Blood Borne Virus Risk Behaviours of Defined 'at risk' Groups
    This report outlines the findings of research with drug users and the staff that support them related to harms associated with chemsex, transactional sex; and the use of image and performance enhancing drugs (IPEDs). Twos aims of the report were to describe the risk-taking behaviours in relation to drug taking, sexual health and transmission of BBV (blood borne virus) of the three target groups and inform the development of a training programme for services providers on sexual health and blood borne viruses for the three defined groups.
    Scotland 07 Sep 2020 Reports & Research PDF
  • Lessons learnt from HepCATT for ODNs and GP practices
    This summary notes some of the lessons learnt from the HepCATT (Hepatitis C Assessment Through to Treatment) Randomised Controlled Trial. HepCATT tested an Hepatitis C virus (HCV) case-finding intervention in primary care. The intervention involved: • Algorithm integrated into electronic patient records systems to identify high risk patients • Automatic mail-merge to create letters to invite high risk patients for testing • Pop-ups alerts in patient records to encourage opportunistic testing • Practice Staff HCV educational training
    UK, England Training, Tools & Templates, Strategy & Planning PDF
  • Good practice case study: Hepatitis C care for homeless individuals in Slough
    This good practice case study, produced by the Turning Point substance misuse service, highlights recent work carried out by nurse and hepatitis C champion Fay Smith in collaboration with colleagues. With previously-homeless individuals accommodated following the Covid-19 outbreak, the opportunity was seized to offer hepatitis C testing and treatment to this cohort.
    South East 17 Aug 2020 Case study PDF
  • Summary Report: Hepatitis C services in Scotland during and beyond the Covid-19 outbreak - August 2020
    With the Covid-19 outbreak having caused significant disruption to health services in Scotland, including those for hepatitis C, as well as drug and alcohol services, HCV Action organised a webinar to discuss how services and the drive to elimination in Scotland have been affected. This report provides a summary of the remarks from each of the four speakers and the Q&A which followed.
    Scotland Case study, Reports & Research, Tools & Templates, Strategy & Planning PDF
  • HCV Action webinar: Hepatitis C services in Scotland during and beyond Covid-19
    With the Covid-19 outbreak having caused significant disruption to healthcare services, including those for hepatitis C, this webinar was organised to discuss how services have been affected in Scotland and explore how hepatitis C services can most effectively be re-established as we emerge from the early phase of the outbreak. The webinar featured contributions from the following speakers: Professor John Dillon - Clinical Lead for Blood Borne Viruses, NHS Tayside Leon Wylie - Lead Officer, Hepatitis Scotland Rachel Halford - CEO, The Hepatitis C Trust
    Scotland 05 Aug 2020 Training, Tools & Templates, Strategy & Planning Video
  • Summary report: Hepatitis C services during and beyond Covid-19 webinar - June 2020
    With the Covid-19 outbreak having caused significant disruption to healthcare services, including those for hepatitis C, HCV Action organised a webinar to discuss how services have been affected in different areas across the country and explore how hepatitis C services can most effectively be re-established as we emerge from the early phase of the outbreak. This report provides a summary of the remarks from each of the four speakers and the Q&A which followed.
    England 24 Jun 2020 Reports & Research, Tools & Templates, Strategy & Planning PDF
  • HCV Action webinar: Hepatitis C services during and beyond Covid-19
    With the Covid-19 outbreak having caused significant disruption to healthcare services, including those for hepatitis C, this webinar was organised to discuss how services have been affected in different areas across England and explore how hepatitis C services can most effectively be re-established as we emerge from the early phase of the outbreak. The webinar featured contributions from the following speakers: • Mark Gillyon-Powell - Head of Programme, HCV Elimination, NHS England & NHS Improvement • Dr Steve Ryder - Chair, HCV Action and Clinical Lead, Nottingham Hepatitis C ODN
    England 22 Jun 2020 Training, Strategy & Planning Video

Pages